Skip to main content

Table 2 Mean CD4 + Tcell count, viral load and haematologic parameters of study participants, grouped by region, age and gender

From: Immuno-haematologic and virologic responses and predictors of virologic failure in HIV-1 infected adults on first-line antiretroviral therapy in Cameroon

 

CD4+ T-cell count

Log10viral load

Mean haematologic parameters ± SD

Variables Category

N

Mean ± SD [cells/μL]

N

Mean ± SD [copies/mL]

N

Hgb [g/dL]

RBC [x106/mm3]

WBC [x103/mm3]

Platelet [x105/mm3]

Region:

         

 Northwest

59

174.9 ± 120.1

75

3.32 ± 1.38

99

11.69 ± 2.21

3.42 ± 0.61

4.24 ± 1.61

2.25 ± 1.05

 Southwest

420

266.7 ± 213.8

273

3.13 ± 1.31

538

12.07 ± 2.00

3.69 ± 0.62

4.41 ± 1.63

2.36 ± 0.77

p-value

  

0.001

 

0.275

 

0.094

< 0.001

0.342

0.199

Age groups (years)

         

 18-29

74

200.1 ± 154.8

75

3.35 ± 1.33♠

87

11.42 ± 1.69†

3.62 ± 0.53

3.99 ± 1.31‡

2.40 ± 0.88

 30-45

278

256.8 ± 198.7♠

195

3.23 ± 1.34♠

371

12.09 ± 2.14

3.69 ± 0.66

4.44 ± 1.79

2.35 ± 0.78

 > 45

127

285.8 ± 242.3♠

78

2.84 ± 1.24

179

12.15 ± 1.94

3.58 ± 0.60

4.45 ± 1.36

2.32 ± 0.86

p-value

  

0.018

 

0.033

 

0.012

0.124

0.049

0.732

Gender

         

 Male

125

241.9 ± 177.9

98

3.13 ± 1.37

158

13.24 ± 2.16

3.93 ± 0.72

4.39 ± 1.55

2.20 ± 0.76

 Female

354

260.1 ± 215.9

250

3.19 ± 1.31

479

11.61 ± 1.83

3.56 ± 0.57

4.39 ± 1.65

2.39 ± 0.83

p-value

  

0.397

 

0.724

 

< 0.001

< 0.001

0.996

0.010

  1. ♠ Higher than 30–45 and > 45 years [P < 0.025], Φ higher than 18–29 years [P < 0.037], § higher than < 12 months [P = 0.03], * higher than < 12 months and 12–36 months [P < 0.001], †lower than 30–45 years and > 45 years [P < 0.005], ‡ lower than 30–45 and > 45 years [P < 0.03].